🇺🇸 FDA
Patent

US 10287305

Substituted piperidine compound and use thereof

granted A61PA61P25/00

Quick answer

US patent 10287305 (Substituted piperidine compound and use thereof) held by Takeda Pharmaceutical Company Limited expires Mon May 09 2039 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Takeda Pharmaceutical Company Limited
Grant date
Tue May 14 2019 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon May 09 2039 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
3
CPC classes
A61P, A61P25/00